Emergent Biosolutions
(EBS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 71,000 | 79,000 | 111,700 | 87,800 | 88,600 |
| Receivables | 196,300 | 233,500 | 191,000 | 216,500 | 290,100 |
| Inventories | 317,500 | 333,400 | 328,900 | 354,100 | 354,300 |
| Other current assets | 33,700 | 0 | 0 | 0 | 0 |
| TOTAL | $654,500 | $682,400 | $679,500 | $720,800 | $777,700 |
| Non-Current Assets | |||||
| PPE Net | 306,200 | 379,400 | 382,800 | 395,400 | 395,500 |
| Intangibles | 534,100 | 550,400 | 566,600 | 582,800 | 811,000 |
| Other Non-Current Assets | 18,700 | 191,400 | 194,300 | 194,100 | 194,600 |
| TOTAL | $859,000 | $1,121,200 | $1,143,700 | $1,172,300 | $1,401,100 |
| Total Assets | $1,513,500 | $1,803,600 | $1,823,200 | $1,893,100 | $2,178,800 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 415,200 | 459,200 | 413,700 | 413,600 | 455,200 |
| Accounts payable and accrued liabilities | 95,900 | 100,200 | 112,200 | 112,700 | 108,300 |
| Accrued Expenses | 83,900 | 56,300 | 92,700 | 99,500 | 100,800 |
| Other current liabilities | 24,700 | 14,500 | 32,700 | 38,200 | 28,900 |
| TOTAL | $619,700 | $630,200 | $651,300 | $664,000 | $693,200 |
| Non-Current Liabilities | |||||
| Long Term Debt | 447,000 | 446,700 | 446,500 | 448,200 | 448,000 |
| Other Non-Current Liabilities | 25,700 | 28,000 | 28,900 | 31,300 | 23,400 |
| TOTAL | $507,500 | $509,500 | $522,600 | $531,900 | $529,300 |
| Total Liabilities | $1,127,200 | $1,139,700 | $1,173,900 | $1,195,900 | $1,222,500 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 52,907 | 52,402 | 52,203 | 51,884 | 51,807 |
| Common Shares | 100 | 100 | 100 | 100 | 100 |
| Retained earnings | -295,900 | -12,800 | -21,800 | 27,700 | 289,700 |
| Other shareholders' equity | -5,200 | -5,200 | -5,400 | -2,300 | -1,300 |
| TOTAL | $386,300 | $663,900 | $649,300 | $697,200 | $956,300 |
| Total Liabilities And Equity | $1,513,500 | $1,803,600 | $1,823,200 | $1,893,100 | $2,178,800 |